EDIXOMED LIMITED

SC363191
Active Edinburgh

Research and experimental development on biotechnology

3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
E

EDIXOMED LIMITED

SC363191

Research and experimental development on biotechnology

Founded 28 Jul 2009 Active Edinburgh, United Kingdom 3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 21 Apr 2026 Next due 30 Apr 2026 2 months overdue
Confirmation Submitted 29 Jul 2025 Next due 11 Aug 2026 1 month remaining
Net assets £-112K £88K 2025 year on year
Total assets £78K £1M 2025 year on year
Total Liabilities £189K £934K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

1 Lochrin Square 92-98 Fountainbridge Edinburgh EH3 9QA United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for EDIXOMED LIMITED (SC363191), an active life sciences and medical technology company based in Edinburgh, United Kingdom. Incorporated 28 Jul 2009. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Aug → 31 Jul 2025
Type total-exemption-full
Next accounts 31 Jul 2025
Due by 30 Apr 2026 2 months overdue

Net Assets, Total Assets & Total Liabilities (2014–2025)

Cash in Bank

£56.13k

Increased by £50.02k (+818%)

Net Assets

-£111.59k

Decreased by £88.33k (-380%)

Total Liabilities

£189.40k

Decreased by £934.21k (-83%)

Turnover

N/A

Employees

3

Debt Ratio

243%

Increased by 141 (+138%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Jul Year End
2024
31 Jul Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

10 Allotments 35,184,438 Shares £19116684.62m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
14 Nov 2018200,000£5k£0.025
14 Nov 201833,333£29k£0.867
17 Oct 2017100,000£3k£0.025
27 Jan 2016773,195£7.732£0
25 Mar 201575,632£0£0

Officers

Officers

1 active 2 resigned
Status
Wilfred Sydney HannaDirectorBritishUnited Kingdom5924 May 2012Active

Shareholders

Shareholders (3)

Thirty Holdings Limited
99.4%
Ian Abercrombie
0.5%

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Professor Christopher Barry Wood

British

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB December 1945
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Active
Notified 16 Nov 2018
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

30 TECHNOLOGY LIMITED united kingdom
EDIXOMED LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
21 Apr 2026AccountsAnnual accounts made up to 31 Jul 2025
21 Apr 2026OtherNotice of agreement to exemption from audit of accounts for period ending 31/07/25
21 Apr 2026OtherAudit exemption statement of guarantee by parent company for period ending 31/07/25
21 Apr 2026AccountsAnnual accounts filed
29 Jul 2025Confirmation StatementConfirmation statement made on 28 Jul 2025 with no updates
21 Apr 2026 Accounts

Annual accounts made up to 31 Jul 2025

21 Apr 2026 Other

Notice of agreement to exemption from audit of accounts for period ending 31/07/25

21 Apr 2026 Other

Audit exemption statement of guarantee by parent company for period ending 31/07/25

21 Apr 2026 Accounts

Annual accounts filed

29 Jul 2025 Confirmation Statement

Confirmation statement made on 28 Jul 2025 with no updates

Recent Activity

Latest Activity

Annual accounts made up to 31 Jul 2025

2 months ago on 21 Apr 2026

Notice of agreement to exemption from audit of accounts for period ending 31/07/25

2 months ago on 21 Apr 2026

Audit exemption statement of guarantee by parent company for period ending 31/07/25

2 months ago on 21 Apr 2026

Annual accounts filed

2 months ago on 21 Apr 2026

Confirmation statement made on 28 Jul 2025 with no updates

10 months ago on 29 Jul 2025